Authors
Latest:
Lessons in Resilience: What HIV Teaches Us About COVID-19Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.
Latest:
Advice for Physicians to Manage C. Difficile Infection (CDI)Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Latest:
Sulbactam for Treatment of Carbapenem-Resistant Acinetobacter baumanniiThis is a challenging pathogen, requiring pharmacokinetic and pharmacodynamic considerations; the recent FDA approval of sulbactam-durlobactam offers new hope.
Latest:
The Tripledemic as a Precursor to Stakeholder Alignment under the Quintuple AimInfectious disease outbreaks will continue to increase and trying to find strategies to ensure providers are cared for to prevent burnout and shortage staffing is essential if another pandemic arises.
Latest:
Advocating for Better Regulatory Rules and Standard of Care for C difficileMaryann Webb’s harrowing, personal experience with C diff, along with her professional work with federal agencies has prepared her for a life in advocacy with the Peggy Lillis Foundation. She wants to see the fecal microbiota transplant become more accessible and is working with Congress to make the infection a notifiable infectious disease.
Latest:
Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to MissAlthough this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.
Latest:
Candida auris: Coming Soon to a Facility Near You?Epidemiologic and clinical lessons for the uninitiated.
Latest:
Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile InfectionsTo close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.
Latest:
Tuberculosis Meningitis in an Immunocompetent PatientRead more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.
Latest:
endTB Trial Paves Way for Shorter, Cheaper, and Safer Rifampin-Resistant TB TreatmentsCarole Mitnick, ScD discusses the impact of the endTB trial's findings on future TB treatment options, including shorter treatment durations, lower costs, and expanded accessibility.
Latest:
An Overview of Cefiderocol Resistance Among Clinical PathogensHere is a review the mechanisms that lead to resistance, including risk factors.
Latest:
Federal Report: Maternal COVID-19 Vaccination Provides Newborn ProtectionNew data demonstrates protection against new variants.
Latest:
STAY PrEPARED: Understanding COVID-19 Pre-Exposure ProphylaxisNew therapeutics offer some hope in this emerging market.
Latest:
Agriculture and Antibiotics: Trying to Protect the Former and Preserve the LatterJennifer Ronholm, PhD, discusses the novel concept of microbiome protection to create healthier animals and reduce antimicrobial usage.
Latest:
Health Equity and the Impact on Infectious DiseaseInequities can include access to care issues that run from prevention to acute treatment. Addressing such issues can lead to better outcomes.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Latest:
Fever of Unknown Origin: What Do We Know and Where Do We Go?As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.
Latest:
The Final Antibiotic Symphony: Harmonizing Diagnostic Accuracy with Antibiotic Treatment in Native Joint Septic ArthritisA study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.
Latest:
Multidrug Resistance in a Patient With HIVIn this case study, clinicians review a challenging case.
Latest:
340B Drug Pricing Program: What Is It and Why Is It Important?The 340B program has had a great impact on access to HIV treatment and prevention services in the US.
Latest:
COVID-19 Convalescent Plasma: What Is Its Role in Therapy?The key is using the right dose on the right patient at the right time.
Latest:
Bringing MRSA Back to the ForefrontJeanine Thomas, president and founder of MRSA Survivors Network, talks about her personal battle with osteomyelitis, her work as an advocate, and the need for data and awareness to bring it to the forefront again.
Latest:
A Rare Case of Positive Heterophile Antibody in a Patient With West Nile VirusThis unusual Case Study describes a young woman who presented with an acute onset of headaches and dizziness and was found to have aseptic meningitis.
Latest:
COVID-19 Booster Shots and the FutureKey opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Latest:
Considerations for Antimicrobial Stewardship While Optimizing Therapy for a Patient With HIVHere is a case study involving a patient with the virus and the clinical approach in thinking about appropriate treatment while keeping stewardship in mind.
Latest:
High-Resistance Therapy Options for Treatment-Naïve Patients With HIVJoseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.
Latest:
An Update on the Pasteur ActAmanda Jezek, of the Infectious Diseases Society of America (IDSA), offers some insight on the prospective bill in Congress, as well as other AMR initiatives the organization is involved in.
Latest:
Case of Rabbit Fever Diagnosed in USThe first 2024 case of tularemia also known as rabbit fever was confirmed in a Wheat Ridge, Colorado resident.
